Skip to Main Content

Paper Details

Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
Pharmacoepidemiol Drug Saf
5
2017

Datasets

Release 1.2